Skip To Main Content
Barbara DeCastro on Muck Rack

Barbara DeCastro

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Authors’ reply to Spiegel and colleagues

|
By Gary Evoniuk, GlaxoSmithKline Research, Bernadette Mansi, Barbara DeCastro
| bmj.com
Gary Evoniuk, director, publications and disclosure (retired)1, Bernadette Mansi, head, publications and disclosure2, Barbara DeCastro, director, publications operations2, Jennie Sykes, vice president, global medical platforms31GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709, USA2GlaxoSmithKline Research and Development, Collegeville, PA, USA3GlaxoSmithKline Research and Development, London, UKgeevoniuk{at}gmail.comWe agree with Spiegel and colleagues that our...
Open in Who Shared Issue with article?

Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies | The BMJ

|
By Gary Evoniuk, GlaxoSmithKline Research, Bernadette Mansi, Barbara DeCastro
| bmj.com
Objectives To determine whether the outcome of drug studies influenced submission and/or acceptance rates for publication in peer reviewed medical journals.
Open in Who Shared Issue with article?
See all 2 articles